| AIDS conspiracy beliefs and unsafe sex in Cape Town E Grebe, N Nattrass AIDS and Behavior 16, 761-773, 2012 | 136 | 2012 |
| Complexity, difference and identity: An ethical perspective P Cilliers, R Preiser Springer Science & Business Media, 2010 | 101 | 2010 |
| Estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status—United States, April 2021–September 2022 JM Jones MMWR. Morbidity and Mortality Weekly Report 72, 2023 | 91 | 2023 |
| Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. W Sykes, L Mhlanga, R Swanevelder, TN Glatt, E Grebe, C Coleman, ... Research Square, 2021 | 84 | 2021 |
| Assessment of HIV transfusion transmission risk in South Africa: a 10-year analysis following implementation of individual donation nucleic acid amplification technology … M Vermeulen, N Lelie, C Coleman, W Sykes, G Jacobs, R Swanevelder, ... Transfusion, 2018 | 69 | 2018 |
| The Treatment Action Campaign's struggle for AIDS treatment in South Africa: coalition-building through networks E Grebe Journal of Southern African Studies 37 (4), 849-868, 2011 | 68 | 2011 |
| Development of antibody biomarkers of long term and recent dengue virus infections EJM Nascimento, JW Huleatt, MT Cordeiro, PMS Castanha, JK George, ... Journal of virological methods 257, 62-68, 2018 | 62 | 2018 |
| Evaluation of commercially available high-throughput SARS-CoV-2 serologic assays for serosurveillance and related applications M Stone, E Grebe, H Sulaeman, C Di Germanio, H Dave, K Kelly, ... Emerging infectious diseases 28 (3), 672, 2022 | 58 | 2022 |
| SARS‐CoV‐2 antibody persistence in COVID‐19 convalescent plasma donors: dependency on assay format and applicability to serosurveillance C Di Germanio, G Simmons, K Kelly, R Martinelli, O Darst, M Azimpouran, ... Transfusion 61 (9), 2677-2687, 2021 | 54 | 2021 |
| Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil CA Prete Jr, LF Buss, R Buccheri, CMM Abrahim, T Salomon, ... BMC infectious diseases 22 (1), 127, 2022 | 43 | 2022 |
| Interpreting HIV diagnostic histories into infection time estimates: analytical framework and online tool E Grebe, SN Facente, J Bingham, CD Pilcher, A Powrie, J Gerber, ... BMC infectious diseases 19, 1-10, 2019 | 41 | 2019 |
| Moving towards a reliable HIV incidence test–current status, resources available, future directions and challenges ahead G Murphy, CD Pilcher, SM Keating, R Kassanjee, SN Facente, A Welte, ... Epidemiology & Infection 145 (5), 925-941, 2017 | 40 | 2017 |
| A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal … H Huerga, F Shiferie, E Grebe, R Giuliani, JB Farhat, G Van-Cutsem, ... BMC infectious diseases 17, 1-8, 2017 | 39 | 2017 |
| Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination SN Facente, E Grebe, K Burk, MD Morris, EL Murphy, A Mirzazadeh, ... PloS one 13 (4), e0195575, 2018 | 37 | 2018 |
| Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022 J Bingham, R Cable, C Coleman, TN Glatt, E Grebe, L Mhlanga, C Nyano, ... Research square, 2022 | 33 | 2022 |
| Performance of the Bio-Rad Geenius HIV1/2 supplemental assay in detecting “recent” HIV infection and calculating population incidence SM Keating, R Kassanjee, M Lebedeva, SN Facente, JC MacArthur, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 73 (5), 581-588, 2016 | 31 | 2016 |
| HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men E Grebe, MP Busch, EP Notari, R Bruhn, C Quiner, D Hindes, M Stone, ... Blood, The Journal of the American Society of Hematology 136 (11), 1359-1367, 2020 | 30 | 2020 |
| Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for incidence surveillance JB Sempa, A Welte, MP Busch, J Hall, D Hampton, SM Keating, ... PLoS ONE 14 (7), e0220345, 2019 | 29 | 2019 |
| Selecting COVID‐19 convalescent plasma for neutralizing antibody potency using a high‐capacity SARS‐CoV‐2 antibody assay E Goodhue Meyer, G Simmons, E Grebe, M Gannett, S Franz, O Darst, ... Transfusion 61 (4), 1160-1170, 2021 | 27 | 2021 |
| Infection staging and incidence surveillance applications of high dynamic range diagnostic immuno-assay platforms E Grebe, A Welte, J Hall, SM Keating, SN Facente, K Marson, JN Martin, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 76 (5), 547-555, 2017 | 26 | 2017 |
Alex WelteStellenbosch UniversityVerificeret mail på sun.ac.za